196 related articles for article (PubMed ID: 37779188)
1. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data.
Li ZM; Liu W; Chen XL; Wu WZ; Xu XE; Chu MY; Yu SX; Li EM; Huang HC; Xu LY
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102318. PubMed ID: 38471582
[TBL] [Abstract][Full Text] [Related]
5. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
6. A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR.
Wang C; Zhao K; Hu S; Huang Y; Ma L; Song Y; Li M
BMC Cancer; 2020 Jun; 20(1):544. PubMed ID: 32522277
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
[TBL] [Abstract][Full Text] [Related]
8. Response Prediction Using
Hu X; Zhou T; Ren J; Duan J; Wu H; Liu X; Mu Z; Liu N; Wei Y; Yuan S
J Nucl Med; 2023 Apr; 64(4):625-631. PubMed ID: 36229183
[TBL] [Abstract][Full Text] [Related]
9. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
[TBL] [Abstract][Full Text] [Related]
10. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
11. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
12. Preoperative CT radiomics of esophageal squamous cell carcinoma and lymph node to predict nodal disease with a high diagnostic capability.
Wu YP; Wu L; Ou J; Cao JM; Fu MY; Chen TW; Ouchi E; Hu J
Eur J Radiol; 2024 Jan; 170():111197. PubMed ID: 37992611
[TBL] [Abstract][Full Text] [Related]
13. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
14. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
15. A machine learning approach using
Qi WX; Li S; Xiao J; Li H; Chen J; Zhao S
Front Immunol; 2024; 15():1351750. PubMed ID: 38352868
[TBL] [Abstract][Full Text] [Related]
16. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
[TBL] [Abstract][Full Text] [Related]
18. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
